GENE K. YEE, PH.D.

**** ******** ** • Melrose, MA 02176 • 781-***-**** tel • 631-***-**** cell • t7k0xb@r.postjobfree.com

SUMMARY

Ph.D. Immunology with 20 years of various Public Relations, Business Development and Outreach, Communications, and Marketing experience in: 501(c)(3) not-for-profit performing arts organizations, 501(c)(3) cancer groups, pharma/biotech, and medical communication agencies. Clients included: Pharma/biotech, National Cancer Institute, disease organizations, medical education and advertising agencies, media, hospital groups, blood products industry, physicians, patients and their advocates, and general public.

Also, 20 years of various medical-writing experience such as: Communications (ie, monographs, speaker training materials; chapters on Targeted Therapies in Breast Cancer and on Cancer Cell Biology); newsletters and journal articles; product cards for early-development program; competitive intelligence reports; NDA writing experience pre-launch, as well as clinical study reports (pre- and post-launch); FDA briefing documents, and PRO questionnaires/instruments for FDA approval in relation to advanced-phase clinical trials.

EXPERIENCE

HEAD, PUBLIC RELATIONS, NORTHSHORE YOUTH SYMPHONY ORCHESTRA (NYSO), TOPSFIELD, MASSACHUSETTS

Public relations for 501(c)(3) performing arts organization, 2010-present

Highlights: NYSO celebrates its 20th anniversary as a premier musical organization of 165+ young musicians (ages 8-18) from 32 cities/towns in the Massachusetts North Shore and Merrimack Valley, and Southern New Hampshire. NYSO’s 4 orchestra ensembles, wind ensemble, and 3 flute choirs do major performances, special concerts and events, and community outreach ("Youth Serving Through Music") throughout the year.

• Direct/implement PR campaign for internet, broadcast, print media; interface with media and benefactors

• Assist in business development/fundraising and marketing

• Work with Symphony, Executive Director, Board, staff, volunteers, parents, community, media, etc.

HEALTHCARE CONSULTANT & FREELANCE WRITER, MELROSE, MASSACHUSETTS

Healthcare, Business Development, Marketing, Medical Communications, 2009-present

Highlights: Consultant Symbeo Healthcare Communications (an ONCommunications Company), Genentech, Novartis, Astellas, Feinstein Kean Healthcare (an Ogilvy PR Worldwide Company), National Cancer Institute (NCI), The Dunn Group, Sanofi-Aventis, Network for Continuing Medical Education, Guidepoint Global

• eProtein NCI Clinical Proteomic Technologies for Cancer (CPTC) newsletter

• Journal articles (eg, Genetic Engineering & Biotechnology News)

• Book chapters: Cancer biology, targeted therapies in cancers

• NCI-CPTC publication/communications plan

• Competitive monitoring for Temusi (NV1-FGF) gene therapy

• Scientific and business consulting (pre- and post-launch, and launch)

• Oncology scientific and medical education

• Sales training (eg, emerging and approved compounds)

THE ANGIOGENESIS FOUNDATION, CAMBRIDGE, MASSACHUSETTS

A 501(C)(3) NOT-FOR-PROFIT ORGANIZATION

Director, Strategic and Business Development, 2008-2009

Highlights: Led Strategic and Business Development and Grants Department that generated $561,000 in 4Q08 2Q09; science education and disease awareness initiatives for patients and their advocates; pre-launch marketing plan with sanofi-aventis for NV1FGF gene therapy in peripheral artery disease/critical limb ischemia; advanced tissue Repair, Revascularization, Regeneration & Reimbursement (R4) expert summit (Oct. 27-28, 2008) and White Paper (industry leaders); educational programs in advanced tissue repair and regeneration: State of the Art, State of the Science (for AHRQ/CMS). Clients: Genentech, Inc., Pfizer Inc., Bristol-Myers Squibb, Boehringer-Ingelheim, sanofi-aventis, GlaxoSmithKline, Bayer HealthCare, Onyx, Amgen, Millennium The Takeda Oncology Company, ImClone, Baxter Heathcare, Cytomedix, Celleration, AnGes, Histogen, Inc.

• Directed strategic and business development with pharmaceutical and biotech industry

• Led department that generated $561,000 in 4Q08 2Q09 (since joining) vs. $200,000 in 4Q07 2Q08 (historic standard)

• Developed strategic partnerships with foundation and advocacy organizations

• Worked closely with President/CEO to develop new programs, budgets, and strategic initiatives; executive-level committee planning

OMNICOM GROUP INC. THE LEADING GLOBAL ADVERTISING, MARKETING AND CORPORATE COMMUNICATIONS COMPANY

MAPI VALUES, BOSTON, MASSACHUSETTS

Director of Scientific Communication, 2007-2008

ADELPHI INC., NEW YORK, NEW YORK

Scientific Director/Editorial Manager, 2006-2007

Boston Highlights: Developed/validated PRO instruments and questionnaires for pharma and FDA; wrote FDA briefing documents and summaries

New York Highlights: Scientific lead for $2 million Roche account in $7 billion U.S. market for pre- and post-launch publication plan (directing/writing clinical articles, reviews, posters, abstracts, monographs); account lead for Novartis early development compound publication plan in oncology/dermatology, and Pfizer neurology, fibromyalgia, epilepsy markets; journal articles/communications; physician outreach/education in Hepatitis B. Clients: Biogen Idec Inc., Roche (C.E.R.A.), Pfizer Inc. (Lyrica), Boehringer-Ingelheim, sanofi-aventis, Novartis (Patupilone, Tyzeka, LBH589), Novo Nordisk, GlaxoSmithKline

• Directed patient-reported outcomes (PROs) publications

• Developed/implemented global strategic communications plan and branding

• Directed/supported key client accounts; wrote business proposals

• Created and directed publications/communications/conference strategy for Patient-Reported Outcomes of Fatigue (PROOF) Consortium, a multi-sponsored FDA collaboration on cancer-related fatigue (also created brand acronym and tag line!)

• FDA briefing documents and summaries

• Participated in business development and commercialization teams

• Taught training sessions

• Directed scientific and strategic initiatives for Roche CERA account ($7 billion market)

• Publication planning: Directed and managed chronic kidney disease/anemia, oncology, epilepsy, and fibromyalgia publications; implemented publication plans

• Gave new business pitches; formulated Hepatitis B initiatives for clinician education

• Conducted competitive intelligence for clients

ROSS COMMUNICATIONS ASSOCIATES, INC., MELVILLE, NEW YORK

Editorial Director, 2000-2006

INTERNATIONAL SOCIETY OF GASTROINTESTINAL ONCOLOGY (ISGIO), MELVILLE, NEW YORK

A 501(C)(3) CORPORATION

Scientific and Managing Editor, 2003-2006

Highlights: Directing/writing scientific articles, journal supplements, reviews, abstracts, monographs, case studies, communications) for pharma (oncology; also analgesia and erectile dysfunction); ISGIO scientific director. Major clients: Sanofi-Aventis (Eloxatin, Taxotere), Bayer HealthCare (Sorafenib), Eli Lilly and Company (Gemzar, Alimta, Cialis, Affinitak), Novartis (Zometa), Pfizer Inc. (Camptosar), MedImmune, Inc. (Ethyol), Genentech, Inc. (Rituxan, Herceptin), OSI (Tarceva), Chiron (Proleukin), Bristol-Myers Squibb (Taxol), Medtronics, Inc. (intrathecal pumps), GlaxoSmithKline (Zofran), ASBD, Consortium on Novel and Targeted Therapies in H&N Cancer (sponsored through the University of Colorado).

• Directed, managed/planned medical communications projects for pharmaceutical clients

- Peer-reviewed articles, journal supplements, brief communications, and case studies; online publications/clinical trials database, annual meeting CD-ROMs, monographs, clinical updates, newsletters, ads, American Society of Clinical Oncology (ASCO) abstracts

- Narrator on ISGIO CD-ROM

- Publications: Cancer, Oncology (Karger), Oncology (US), Clinical Breast Cancer, Lung Cancer, Clinical Lung Cancer, European Journal of Cancer, Seminars in Oncology, Seminars in Radiation Oncology, Oncology News Intl., Journal of Pain and Symptom Management

- Therapeutic areas: Oncology (glioma, lung, pancreas, colorectal, GI/GU, breast, and head and neck [H&N] cancer; lymphoma; supportive care), radiation oncology, targeted therapies, pain medicine, erectile dysfunction

- Network for Oncology (and Medical) Communications Research

- Corporate-sponsored symposia, congresses, investigators’ meetings

- Annual meetings: ISGIO GI Oncology Conference; Novel & Targeted Therapies in H&N Cancer; American Society for Breast Disease (ASBD)

- CME-accredited meetings, monographs (ACCME credit furnished by Beam Institute and The Institute of Medicine)

MOORE COMMUNICATIONS, INC., NEW YORK, NEW YORK

Managing Editor, 1998-2000

Highlights: Directing/writing medical communications (ie, monographs, speaker training materials, CME programs, advisory boards) for pharma (Hepatitis B; also allergy, influenza, GI, and migraine); community outreach, patient education, and physician training in Hepatitis B. Major clients: GlaxoSmithKline (Epivir HBV, Navelbine, Relenza, Flonase, Epivir, Lotronex), Janssen Pharmaceutica (Topamax).

• Directed and managed communications projects for pharmaceutical clients

- Satellite symposia (independent – CME); commercial exhibit symposia

- Symposia spinoffs (internet programs & monographs; highlighters)

- CD-ROMs; product/meeting slide kits (& online kits); patient education pieces

- Speaker training meetings, advisory boards, special issues boards, clinical advisory panels, and national teleconference series; PR work

- Business proposals & budget estimates; executive & topline summaries

- Opinion and thought leader development/recruitment; market analysis

- Media kits, sales primers, and teleconference reports; journal ads

• Therapeutic areas: Hepatitis B, allergy, influenza, infectious disease, bipolar disorder, epilepsy, irritable bowel syndrome, migraine, oncology

• Program administrator for GlaxoSmithKline Institute for Digestive Health foundation ($750,000 in annual research grants); Asian community outreach (Hepatitis B)

• Managed associate/assistant editors, writers, and graphics & web designers

• Composed/edited journal ads, mtg packets, communications, and graphics

• Attended trade shows; staffed client booths; met with clients; press releases

• Designed company web site (web master); produced internet programs

PALL BIOMEDICAL PRODUCTS COMPANY, EAST HILLS, NEW YORK

Scientist Lecturer/Marketing, 1992-1998

Highlights: Global medical marketing lead for hospital markets for biomedical devices (N. America/Asia-Pacific Rim) in hematology-oncology, surgery, CV, anesthesia, and critical care; American Red Cross training and corporate training

• Created, presented, and managed CME-accredited seminars for MDs at hospitals, meetings, and trade shows – Blood (surgery, oncology, blood processing) & cardiovascular market (eg, literature, promos, slides)

• Averaged 120 presentations per year (North America and Asia Pacific Rim)

• Special “high-profile” marketing projects for various markets

- Canadian Blood Authority countrywide filtration initiative

- FDA reclassification (filter industry consortium application)

- Clinical studies: St. Luke’s-Roosevelt Hosp., NY; Cleveland Clinic, OH

- American Society of Colon and Rectal Surgeons campaign

- Aetna-U.S. Healthcare brief; Pall stockholders presentation and PR

• Conducted competitive intelligence

• Investigated new product markets; wrote marketing bulletins, direct mail, & market analyses; edited/disseminated foreign pieces; wrote training manuals

• Helped create strategic marketing plan; developed position pieces

• Wrote/edited ads, brochures, & trade show promos; edited product labeling

• Created copy for www.pall.com site; answered internet queries

• Wrote media/newsletter articles

• Shot/edited surgery market video for corporate board; Pall anniversary video

• New product development, clinical studies, and customers’ sales/product objections; focus groups for new filter technology and product applications

• Closed sales, neutralized competition/customer objections, and converted accounts; extensive field work with sales persons and customers; trade shows

• Trained sales managers, distributors, and American Red Cross sales staff

• Trained and advised Pall Asia personnel; quality internal review processes

BOSTON UNIVERSITY SCHOOL OF MEDICINE AND TUFTS UNIVERSITY SCHOOLS OF MEDICINE, BOSTON, MASSACHUSETTS

Research Associate (Molecular Biology/Dermatology), 1991-1992

Post-doctoral Fellow (Pathology), 1989-1991

Highlights: Post-doctoral research in dermatology and molecular biology (under Barbara Gilchrest, M.D.), and pathology (Richard Miller, MD, Ph.D.) at Boston University School of Medicine, and U.S.D.A. Human Nutrition Research Center on Aging at Tufts University

• NIH-funded research on tumor suppressor genes in skin cancers

• NIH-funded research on oncogenes in immunologic aging and transcription regulation in liver

EDUCATION

UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON AND M.D. ANDERSON CANCER CENTER

Ph.D. Immunology, 1988

Highlights: Photo-immunology research in skin (under Margaret Kripke, Ph.D.); post-doctoral research in dermatology and molecular biology (under Barbara Gilchrest, M.D.), and pathology (Richard Miller, MD, Ph.D.) at Boston University School of Medicine, and U.S.D.A. Human Nutrition Research Center on Aging at Tufts University

Major honors and awards: Rosalie B. Hite Merit Award (for “outstanding research”); Rosalie B. Hite Fellowship (3-yr, competitive/renewable); R.E. “Bob” Smith Fellowship

UNIVERSITY OF CALIFORNIA AT BERKELEY

B.A. Microbiology and Immunology, 1982

SELECTED OUTREACH EXPERIENCE

NORTHSHORE YOUTH SYMPHONY ORCHESTRA

• Community Outreach ("Youth Serving Through Music") concerts (eg, “Thanksgiving Project” First Church Ipswich) and public relations (2010-2011)

REI, INC.

• Supported Outreach Department in REI-sponsored events (informally assisting spouse and REI Sales Specialist Jennifer Yee at Store #26)

- New annual clinic “Camp Cooking Basics” (6/17/10; 6/25/11; 7/6/2011): Set-up, A/V, demos

- 3rd-Annual Healthy Melrose Family Wellness and Fitness Fair (4/30/11): Set-up, photography

- 9th-Annual Walk of Hope to Benefit ALS, Wakefield (8/28/10): Photography

- Video segment on Snowshoeing for “Fit Choice,” Melrose Mass. TV (3/4/10): Photography

- Town of Reading Friends and Family Day (9/10/10): Photography

THE ANGIOGENESIS FOUNDATION

• Educational outreach programs for patients and their advocates; in conjunction with patient groups (eg, Lance Armstrong Foundation LiveStrong Global Cancer Campaign, American Cancer Society), disease societies (eg, American Society of Retinal Specialists), patient/physician advocacy groups, and pharma/biotech advocacy departments (eg, Genentech); (2008-2009)

NORTHERN FOREST CANOE TRAIL (NFCT)

• “Serve and Splash Weekend” outreach program with “REI Gives” partner NFCT (2008)

• The Northern Forest Canoe Trail: The Official Guidebook (The Mountaineers Books: Seattle, WA: 2010, pp. 150, 203)

BOSTON SYMPHONY ORCHESTRA (BSO)

• Youth Education and Community Programs (1989-1992): Tours, pre-concert lectures, and concerts

• Days in the Arts (DARTS; 1989-1992; 2008-2009): Tours, pre-concert lectures, and concerts

• Adult Education (1989-1992): Tours and fundraising

• “Crescendo” Series and Outreach events (1989-1992): A successful series geared to attract young urban (or young upwardly mobile) professionals to regular concerts

BOSTON UNIVERSITY SCHOOL OF MEDICINE

• Medicine for Medical Technologists (1990)

UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AND M.D. ANDERSON CANCER CENTER

• High School Teachers Workshops (1987-1988)

• Science Fairs (1986-1988)

KUHF PUBLIC RADIO AND HOUSTON SYMPHONY

• Outreach, advertising, and fundraising events (1984-1988)

TRAINING EXPERIENCE

THE ANGIOGENESIS FOUNDATION, 2008-2009

• Business development and program materials for “Angiogenesis Training” for pharma and medical education agencies (field and off-site)

MAPI VALUES, 2007-2008

• Executive summary training sessions (+ slides) for assistant directors, project managers, research associates, and research assistants (in-house)

• Copy-editing training sessions (+ slides) for project managers, research associates, and research assistants

ADELPHI, 2006-2007

CERA (Mircera) for Roche Laboratories

• Training, hiring, and orientation for Copy Editors and Medical Writers (in-house), educational development

ROSS COMMUNICATIONS/ISGIO, 2000-2006

Eloxatin (oxaliplatin) for Sanofi-Synthelabo

• Clinical trials/publication online database training for MSLs (Dallas, TX), Marketing (NY, NY), Global/France (NY, NY), and R&D (Malvern, PA)

• Development, proof-of-concept, launch, implementation, update/maintenance of global clinical trials/publication online database

General editorial/ISGIO operations

• Training of Editorial Assistant Managing Editor (in-house); educational development

MOORE COMMUNICATIONS, 1998-2000

Epivir HBV (lamivudine) for GlaxoWellcome

• National speaker training for physicians – multiple sites (hotel properties)

• Speaker training logistics and editorial

• Speaker training slide kits and educational materials

Flonase (fluticasone propionate) for GlaxoWellcome

• National speaker training for physicians – multiple sites (hotel properties)

• Speaker training logistics and editorial

• Speaker training slide kits and educational materials

PALL CORPORATION, 1992-1998

• American Red Cross sales and scientific training (ARC Headquarters, Washington, DC)

• Regional Manager and Distributor product training (in-house and field)

• Pall Asia Scientist Lecturer training (in-house, Singapore); slide kits, educational materials

• Pall N. America Scientist Lecturer orientation and training (in-house; slides, educational materials)

• Corporate Board video presentation and training

• Note: Scientist Lecturer-Marketing was a 70% field position, interacting with Regional Sales Managers, Distributors, and Physicians (and nursing and medical staff)

PROFESSIONAL SOCIETIES/GROUPS

• International Brotherhood of Magicians

• New England Magic Collectors Association

• Greyhound Friends

• Northern Forest Canoe Trail

• WGBH Public Media

• Isabella Stewart Gardner Museum

• Boston Museum of Science

• American Society of Clinical Oncology

• MetroRock, Basic Top Rope Climber (belaying/knots/equipment/safety)

• Wilhelm Furtwängler Society of America

• United States Naval Institute (Silver Member 25 years)

INDUSTRY, AGENCY, 501(C)(3), AND PERFORMING ARTS REFS. AVAILABLE ON REQUEST

Biosketch

Gene Yee, Ph.D., is a healthcare consultant (and freelance medical writer), with expertise in business development, marketing, medical communications, public relations, and competitive intelligence. (Recently, he provided competitive intelligence as a consultant for Sanofi-Aventis for Temusi (NV1-FGF) gene therapy to treat peripheral artery (PAD) and cardiovascular (CV) diseases via therapeutic angiogenesis.) He has covered/attended major conferences, eg, American Heart Association, American Society of Gene & Cell Therapy, American Society of Clinical Oncology, National Kidney Foundation, American Gastroenterological Association, American Society of Hematology. Dr. Yee is also Head, Public Relations for the Northshore Youth Symphony Orchestra, a performing arts 501(c)(3) based in Topsfield. On the political front, Dr. Yee ran for Alderman-at-Large for Melrose, MA, in 2011. He was previously Director, Strategic and Business Development at The Angiogenesis Foundation (Cambridge, MA), the world’s first and only 501(c)(3) for angiogenesis-based cancer and disease medicines. He led them to new fundraising heights: $561,000 in 4Q08 2Q09 vs. $200,000 in 4Q07 2Q08 (historic standard), including alliances with companies (Sanofi-Aventis, AnGes, Genzyme, Baxter) developing gene and cell therapies to treat PAD and CV disease, as well as manufacturers of anti-angiogenic targeted cancer therapies (Genentech, Bayer, Pfizer, GlaxoSmithKline, AstraZeneca, etc.), including renal cell, lung, colon, breast, GI, and other angiogenic-dependent cancers. Prior to this, he was Scientific Director and Director of Scientific Communication at Omnicom Group Inc. the leading global advertising, marketing, and corporate communications company, where in NYC, he led a $2 million Roche account (in a $7 billion chronic kidney/anemia market) for pre-launch publication planning. Other publication plans (which Adelphi pioneered in 1986) included a Novartis plan for emerging compounds in prostate, dermatologic, and solid cancers, and a major Pfizer Lyrica (pregabalin) account in neurology, pain, epilepsy, and fibromyalgia. For the Boston Omnicom affiliate, he did publication planning for a Consortium on fatigue in cancer (encompassing the FDA, industry, and research institutes), and patient-oriented outcomes (PRO) research for use as FDA-approved endpoints in advanced phase trials. Prior to Omnicom, Dr. Yee was Editorial Director at Ross Communications, specializing in oncology publications, including a major publication plan and marketing in prostate and breast cancers for Novartis a major manufacturer of bone agents Zometa (zoledronic acid) and Aredia (palmidronate disodium), as well as Bayer (Nexavar), Eli Lilly (Gemzar), Sanofi-Aventis (Eloxatin), and other companies with anti-cancer agents in renal cell (RCC), prostate, lung, breast, gastrointestinal, colorectal, brain, head & neck, and other cancers, including sponsors Bristol Myers Squibb, Pfizer, and MedImmune. (Other publications covered analgesia and erectile dysfunction.) He was also Scientific and Managing Editor of the International Society of Gastrointestinal Oncology (ISGIO), a 501(c)(3). Before this, he was Managing Editor at Moore Communications in NYC, in the areas of infectious disease (Hepatitis B), GI, and psychiatry. Dr. Yee has also been a Scientist-Lecturer (Marketing) for Pall Corporation, the world leader in filtration technology (East Hills, NY), with biomedical device marketing in CV surgery (as well as cardioplegia and transplantation), hematology-oncology, orthopedic and colorectal surgery, and critical care/anesthesia for N. America/Asia-Pacific Rim (~120 annual presentations), and executing in-house/field marketing, training, and competitive intelligence. He also developed/supported a countrywide initiative for the Canadian Red Cross’ universal implementation of leukocyte filtration, and trained the American Red Cross on cell filtration. Prior to private industry, he conducted Ph.D.-level research at Boston University and Tufts Medical Centers in Molecular Biology, Pathology, and Dermatology.

Dr. Yee has a plethora of experience in renal cell carcinoma (RCC), solid, and lymphocytic tumor types. As an example in just one tumor type, while Director at The Angiogenesis Foundation, he led and developed business collaborations with major pharmaceutical companies who currently market and develop anti-angiogenic therapies in RCC (eg, Bayer, Pfizer, GlaxoSmithKline, Genentech, AstraZeneca, etc.). These ranged from clinical/physician education, patient resources, and outreach for patients and their advocates. While Editorial Director at the International Society of Gastrointestinal Oncology (ISGIO), Dr. Yee directed and wrote Oncology journal articles and supplements, as well as Oncology News International articles to support the product launch of Nexavar (Sorafenib). He also directed and/or wrote publications supporting the clinical use of conventional chemotherapy to treat RCC for another major pharmaceutical sponsor. As a member of a major oncology publications agency and the ISGIO, he helped develop and implement an international clinical trials and publications database for a clinical program for GI carcinomas, including RCC. In this regard, Dr. Yee also directed and implemented series of advisory boards, investigator meetings, and conferences that covered RCC. Dr. Yee’s experience is similar across multiple tumor types, gene and cell therapy, and biotechnology (proteomics).

Regarding regulatory work, Dr. Yee has prepared FDA briefing documents (in oncology (2005-7), cancer-related fatigue (2007-8), obesity (2007-8), chronic kidney/anemia (2006-7), and gene therapy for peripheral artery disease (2010). He also worked on pre-submission work to FDA in oncology (2005-7) and chronic kidney anemia (2006-7), and submission work to FDA in oncology (2005-6). Dr. Yee also authored a industry consortium application to FDA to re-classify (by amendment) medical devices in hematology-oncology, surgery, and CV surgery (1997-8). He also worked with FDA on patient-reported outcomes (including FDA briefing documents, patient-reported outcomes [PROs], and questionnaires) (2007-8), and with FDA's Division of Drug Marketing, Advertising and Communications (DDMAC) on product labeling claims (in cancer-related fatigue), (2007-8). Dr. Yee also has experience with FDA 510(k) device submissions and premarket notifications (2010). Regarding other regulatory agencies, he has also interacted with EMEA (1997-8, 2007, 2009).

Dr. Yee earned a Ph.D. in Immunology from The University of Texas Health Science Center, Houston, and M.D. Anderson Cancer Center. He received a B.A. in Microbiology and Immunology from The University of California, Berkeley.

Dr. Yee’s outside interests include history of stage illusion and magic, Houdini, and classical music history. He also led tours of Symphony Hall, Boston, and participated in Boston Symphony Orchestra Youth Education, audience development, and fund-raising. His wife Jennifer and he are noted magic collectors and historians, and perform large, dramatic stage illusions as “Yee Magik.” The Yees reside at historic Heathman Manor in Melrose, MA (former residence of famous mentalist and magician Anna Eva Fay Jennifer’s great grandaunt and Houdini’s friend). Madame Fay headlined worldwide, performed for royalty, and was the first woman inducted into the prestigious Magic Circle U.K. Their favorite charities include Greyhound Friends, The Northern Forest Canoe Trail, WGBH, Isabella Stewart Gardner Museum, Museum of Science, North Shore Cancer Walk, and Bike MS (Cape Cod Getaway). They also hike, paddle, and are active in historic stewardship, conservation, and their rescued racing greyhound!

Contact this candidate